Inotiv, Inc.
General ticker "NOTV" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $84.6M (TTM average)
Inotiv, Inc. does not follow the US Stock Market performance with the rate: -1.0%.
Estimated limits based on current volatility of 3.0%: low 0.85$, high 0.92$
Factors to consider:
- Total employees count: 2075 (+6.1%) as of 2024
- US accounted for 85.4% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Declining NHP sales, Going concern, Liquidity and credit risks, Hazardous materials liability, Acquisition/divestiture risks
- Current price 24.8% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [1.08$, 3.34$]
- 2025-09-30 to 2026-09-30 estimated range: [1.17$, 3.51$]
Financial Metrics affecting the NOTV estimates:
- Positive: with PPE of -1.3 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -15.90 <= 0.33
- Positive: 18.93 < Shareholder equity ratio, % of 21.82 <= 41.86
- Positive: Industry inventory ratio change (median), % of -0.81 <= -0.15
- Positive: Inventory ratio change, % of -5.35 <= -0.75
Short-term NOTV quotes
Long-term NOTV plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $547.66MM | $572.42MM | $490.74MM |
| Operating Expenses | $811.11MM | $653.88MM | $577.14MM |
| Operating Income | $-263.45MM | $-81.46MM | $-86.41MM |
| Non-Operating Income | $-89.00MM | $-42.78MM | $-44.35MM |
| Interest Expense | $29.70MM | $43.02MM | $46.88MM |
| Income(Loss) | $-352.45MM | $-124.24MM | $-130.76MM |
| Taxes | $-15.19MM | $-19.34MM | $-21.88MM |
| Profit(Loss)* | $-337.02MM | $-105.14MM | $-108.44MM |
| Stockholders Equity | $360.37MM | $269.15MM | $170.50MM |
| Inventory | $71.44MM | $56.10MM | $18.17MM |
| Assets | $962.90MM | $856.53MM | $781.36MM |
| Operating Cash Flow | $-5.22MM | $27.88MM | $-6.80MM |
| Capital expenditure | $36.30MM | $27.50MM | $22.31MM |
| Investing Cash Flow | $-333.72MM | $-28.75MM | $-16.83MM |
| Financing Cash Flow | $203.15MM | $15.87MM | $9.68MM |
| Earnings Per Share** | $-13.84 | $-4.10 | $-4.19 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.